Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Diseases

Explore clinical trials studying Biliary Tract Diseases. Study availability and eligibility vary by location and protocol.

1,498 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Diseases trial results

Active, Not Recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health Chandler, Arizona, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 115 locations
View Trial Details
Active, Not Recruiting

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

NCT05036486

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Chang Gung Memorial Hospital, Chiayi Chiayi City, Taiwan
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

NCT05035030

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • UCSF San Francisco, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Riley Hospital for Children at IU Health Indianapolis, Indiana, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

NCT05564403

Conditions
Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

NCT05775159

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Kansas City, Kansas, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

NCT05170438

Conditions
Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details

Related conditions